-
A new treatment for pancreatic cancer has been developed that on average increases survival from from six months to 12 but Canadians don’t have access to it. Here’s why.
Medical Mythbusting Commentary for July 15, 2026 Source:A new cancer treatment is hailed as a breakthrough, but Canadians don’t have access to it. Here’s why.
-
An antipsychotic medication quetiapine used off-label as a sleep aid can affect sleep quality and concentration in untreated sleep apnea patients.
Medical Mythbusting Commentary for June 23, 2026 Source:A Commonly Used Sleep Aid May Have a Dangerous Side Effect Reference:Quetiapine modestly improves sleep and breathing but impairs next day performance in people with OSA and difficulty maintaining sleep: A randomized controlled trial
-
Large psilocybin dose briefly improved dementia in case study of an 80 year-old woman. Larger controlled studies are required
Medical Mythbusting Commentary for June 15, 2026 Source:Large psilocybin dose briefly improved dementia in case study Reference:Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case report
-
Explain to parents why Vitamin K administration at birth is a safe and effective means of preventing neonatal bleeding conditions. More parents are saying no to the shot due to misinformation.
Medical Mythbusting Commentary for June 12, 2026 Source:More parents are saying no to newborn vitamin K shots. Experts are concerned. Reference: The following patient handout synthesizes the information discussed across this conversation, covering the rationale for vitamin K at birth, sources of vitamin K, types and symptoms of vitamin K deficiency bleeding, and the outcomes…
-
New antibiotic kills drug-resistant bacteria by targeting previously unknown vulnerability
Medical Mythbusting Commentary for June 8, 2026 Source:New antibiotic kills drug-resistant bacteria by targeting previously unknown vulnerability Reference: A natural depsipeptide antibiotic binds the E-site of the bacterial ribosome
-
The mechanism of why statin medications can cause muscles aches has been outlined but this pathway is found in a minority of patients so other reasons remain elusive.
Medical Mythbusting Commentary for June 3, 2026 Source:A Painful Side Effect of Statins Explained After Decades of Mystery Reference:Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation
-
New medication for the treatment of advanced pancreatic cancer increases median overall survival from 6.7 to 13.2 months.
Medical Mythbusting Commentary for June 1, 2026 Source:‘I actually started crying’: Oncologist reacts to pancreatic cancer drug results Synopsis of the article and study: Benefits: Doubled survival, oral convenience, targeted action, manageable side effects. Limitations: Grade 3+ adverse events in about one-third of patients; still experimental, not yet fully approved; tested in advanced cases post-chemo.
-
Beta-blockers, taken by millions after a heart attack, found to be ineffective for people with uncomplicated heart attacks (normal heart function thereafter) and presents increased risk of harm to women. Changes to management likely in the works for this population.
Medical Mythbusting Commentary for May 27, 2026 Source:Common heart drug taken by millions found useless — and possibly dangerous Reference:Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial
-
Observational study noted that patients with diabetes and obesity using GLP-1 medications may experience reduced degree of metastases. Causality confirmation and mechanisms to be determined.
Medical Mythbusting Commentary for May 25, 2026 Source:GLP-1 Users May Experience A Surprising Life-Saving Benefit That Has Nothing To Do With Weight Loss